Evidence map›Paper›PMID 33138774›Full record

ArticleBMC medical genetics2020

NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study.

Kanika Singh, Sunita Bijarnia-Mahay, V L Ramprasad, Ratna Dua Puri, Sandhya Nair, Sheetal Sharda, Renu Saxena, Sudha Kohli, Samarth Kulshreshtha, Indrani Ganguli and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Lancet regional health. Southeast Asia · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kanika SinghInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Sunita Bijarnia-MahayInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India. bijarnia@gmail.com.ORCID 0000-0002-5255-8212
V L RamprasadMedgenome Laboratories Pvt Ltd., Bangalore, India.
Ratna Dua PuriInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Sandhya NairMedgenome Laboratories Pvt Ltd., Bangalore, India.
Sheetal ShardaMedgenome Laboratories Pvt Ltd., Bangalore, India.
Renu SaxenaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Sudha KohliInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Samarth KulshreshthaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Indrani GanguliInstitute of Obstetrics and Gynaecology, Sir Ganga Ram Hospital, New Delhi, India.
Kanwal GujralInstitute of Obstetrics and Gynaecology, Sir Ganga Ram Hospital, New Delhi, India.
Ishwar C VermaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India. icverma@gmail.com.
Sir Ganga Ram Hospital · INSciGenom Labs (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo determine the carrier frequency and pathogenic variants of common genetic disorders in the north Indian population by using next generation sequencing (NGS).

methodsAfter pre-test counselling, 200 unrelated individuals (including 88 couples) were screened for pathogenic variants in 88 genes by NGS technology. The variants were classified as per American College of Medical Genetics criteria. Pathogenic and likely pathogenic variants were subjected to thorough literature-based curation in addition to the regular filters. Variants of unknown significance were not reported. Individuals were counselled explaining the implications of the results, and cascade screening was advised when necessary.

resultsOf the 200 participants, 52 (26%) were found to be carrier of one or more disorders. Twelve individuals were identified to be carriers for congenital deafness, giving a carrier frequency of one in 17 for one of the four genes tested (SLC26A4, GJB2, TMPRSS3 and TMC1 in decreasing order). Nine individuals were observed to be carriers for cystic fibrosis, with a frequency of one in 22. Three individuals were detected to be carriers for Pompe disease (frequency one in 67). None of the 88 couples screened were found to be carriers for the same disorder. The pathogenic variants observed in many disorders (such as deafness, cystic fibrosis, Pompe disease, Canavan disease, primary hyperoxaluria, junctional epidermolysis bullosa, galactosemia, medium chain acyl CoA deficiency etc.) were different from those commonly observed in the West.

conclusionA higher carrier frequency for genetic deafness, cystic fibrosis and Pompe disease was unexpected, and contrary to the generally held view about their prevalence in Asian Indians. In spite of the small sample size, this study would suggest that population-based carrier screening panels for India would differ from those in the West, and need to be selected with due care. Testing should comprise the study of all the coding exons with its boundaries in the genes through NGS, as all the variants are not well characterized. Only study of entire coding regions in the genes will detect carriers with adequate efficiency, in order to reduce the burden of genetic disorders in India and other resource poor countries.

Indexed as

Acyl-CoA DehydrogenaseAdultCanavan DiseaseConnexin 26ConnexinsCystic FibrosisEpidermolysis Bullosa, JunctionalFemaleGalactosemiasGene ExpressionGenetic Carrier ScreeningGenetic CounselingGlycogen Storage Disease Type IIHearing Loss, SensorineuralHeterozygoteHigh-Throughput Nucleotide SequencingAcyl-CoA DehydrogenaseConnexin 26ConnexinsGJB2 protein, humanMembrane ProteinsNeoplasm ProteinsSerine EndopeptidasesSLC26A4 protein, humanSulfate TransportersTMC1 protein, humanTMPRSS3 protein, humanAsian IndiansCarrier screeningCystic fibrosisHearing lossPompe disease

Identifiers

PMID33138774
PMCPMC7607710
OpenAlexW3095621878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.